# Preoperative ROS1-TKI Therapy for ROS1 Fusion-Positive Locally Advanced Lung Adenocarcinoma

> **NCT07700836** · — · COMPLETED · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 12 (actual)

## Conditions studied

- ROS1 Fusion-Positive Lung Adenocarcinoma

## Interventions

- **DRUG:** ROS1-TKI Therapy

## Key facts

- **NCT ID:** NCT07700836
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-01
- **Primary completion:** 2025-09-03
- **Final completion:** 2025-11-17
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2026-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07700836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07700836, "Preoperative ROS1-TKI Therapy for ROS1 Fusion-Positive Locally Advanced Lung Adenocarcinoma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07700836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*